US Stock MarketDetailed Quotes

TERN Terns Pharmaceuticals

Watchlist
  • 7.370
  • -0.590-7.41%
Close Jun 18 16:00 ET
  • 7.550
  • +0.180+2.44%
Post 19:36 ET
476.67MMarket Cap-5849P/E (TTM)

Terns Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Terns Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.30

+3.23%
Analyst Rating

Strong Buy

May 31, 2024

Terns Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Terns Pharmaceuticals Earnings Reports

  • Terns Pharmaceuticals | 10-Q: Quarterly report

    May 13 16:19 ET

  • Terns Pharmaceuticals | 10-K: Annual report

    Mar 14 16:22 ET

  • Terns Pharmaceuticals: Q3 2023 Earnings Report

    Nov 14, 2023 08:30 ET

  • Terns Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:53 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 31, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg